office: Fulginiti Pavilion - Room 201
Professor Bero is a leader in evidence synthesis, meta-research and studying commercial determinants of health, focusing on tobacco control, pharmaceutical policy, and public health. She provides international leadership for multidisciplinary teams that specialize in studying the quality, use and implementation of research for health and health policy. She is Senior Editor, Research Integrity for the Cochrane Collaboration and was Co-Chair of the Cochrane Governing Board 2014-18.
Dr. Bero has developed and validated qualitative and quantitative methods for assessing bias in the design, conduct and dissemination of research. She has pioneered the utilization of internal industry documents and transparency databases to understand corporate tactics and motives for influencing research evidence.
She is internationally recognized for her work on evidence synthesis, bias, conflicts of interest and use of evidence in decisions as shown by media coverage, speaking invitations and service on national and international committees, such as US National Academies of Science Committees, the World Health Organization Essential Medicines and guideline committees.